Among 380 bone marrow transplant (BMT) recipients, five cases (1.3%) of clonorchiasis were observed from 1991 to 1996. Clonorchis sinensis infection was evident in the results of stool examinations performed for screening purposes 7 days before bone marrow transplantation. Salmonella species were isolated concomitantly from the stools of two of the five patients. None of the patients had symptoms due to clonorchiasis. Ultrasonography did not show dilated hepatobiliary ducts, stones, or periportal fibrosis. Fatty liver changes were detected in one patient. All five patients received praziquantel (25 mg/kg po t.i.d. for 1 day) before bone marrow transplantation. Only two patients who underwent allogeneic transplantation had mild venoocclusive disease of the liver with transient hyperbilirubinemia and mildly elevated liver enzyme levels, whereas hyperbilirubinemia or elevated serum alanine aminotransferase levels, related to conditioning toxicity, occurred in two other patients. After treatment with praziquantel, stool examinations for all five patients were negative for C. sinensis ova. In addition, Salmonella species were not detected after ciprofloxacin prophylaxis. All five patients survived for ú300 days. Given the availability of effective therapy and in the absence of excessive complications, clonorchiasis is not a contraindication to bone marrow transplantation.
Patients who undergo bone marrow transplantation are prebone marrow transplantation. Infection due to Clonorchis sinensis is endemic in South China. In Hong Kong, 2.2% of disposed to serious bacterial, viral, and fungal infections, most of which have been well studied. However, parasitic infections, the population is infected with this trematode (P.C.Y. Woo, unpublished data). Because patients with serious infections may especially helminthic diseases, are not encountered frequently among bone marrow transplant (BMT) recipients, since these experience recurrent cholangitis and because there are no reports concerning flares of cholangitis during preparative chediseases are more common among patients in developing countries. The most common and important parasites that cause motherapy and subsequent neutropenia among patients who undergo bone marrow transplantation, we report our experience infections in BMT recipients include Pneumocystis carinii [1] , Toxoplasma gondii [2] , Giardia lamblia [3], microsporidia [4] , with clonorchiasis among BMT recipients. and Cryptosporidium parvum [5] . Infections due to geographically restricted parasites such as Trypanosoma [6] , AcanthaPatients and Methods moeba [7] , Plasmodium [8] , Schistosoma [9] , Trichostrongylus Data from BMT recipients were recorded systematically dur- [10] , and Strongyloides [11] may occur occasionally. However, ing a 6-year period (1991 -1996) , during which bone marrow with the inception of more BMT centers in developing countransplantation was performed on 380 patients at the Queen tries, as well as the migration of people from developing to Mary Hospital (Hong Kong). The transplantation protocols and developed countries, larger numbers of parasitic infections are antimicrobial and graft-versus-host disease prophylaxis have anticipated among BMT recipients. It is of interest that among been described previously [12] . patients with schistosomiasis, periportal fibrosis has been assoStool was obtained from all BMT recipients 7 days before the ciated with increased risk of venoocclusive disease (VOD) after procedure. The specimens were inoculated onto deoxycholate citrate agar and xylose lysine deoxycholate agar for detection of potential gastrointestinal pathogens. In addition, the specimens were concentrated by using the formalin-ether method, and wet ever, international travel and increasing affluence in certain areas of endemicity have resulted in carriers of parasites being donors and recipients of BMTs. In addition to its prevalence Results among BMT recipients, clonorchiasis is prevalent in our localAmong 380 BMT recipients, five cases (1.3%) of clonorchiity. C. sinensis ova were detected in the stool samples of five asis were observed (table 1); the median age was 40 years. All of 380 BMT recipients 7 days before their procedures, with an patients were hepatitis B surface antigen (HBsAg) negative; incidence (1.3%) comparable to that for the general population. three patients were positive for hepatitis B surface antibody
The only report of clonorchiasis in transplant recipients in (HBsAb) because of previous vaccinations (cases 2, 4, and 5).
the literature concerns liver transplantation in our locality [13] . None of the patients' symptoms were attributable to clonorchiIn that report of two cases, adult worms of C. sinensis were asis. Light microscopic examination (magnification, 1400) reobserved in the donors' livers during organ procurement. Alvealed light yellow-brown operculated eggs, 29 1 16 mm, though the parasites were killed by cold perfusion, they caused with a small median protuberance at the thicker posterior end, blockage of the hepatojejunostomy splintage tube and cessation characteristic of C. sinensis ova, for all five patients undergoing of bile flow during the early postoperative period for one of pretransplantation screening. It is of interest that Salmonella the recipients. species were also isolated from two of the five patients (cases Clonorchiasis does not appear to be associated with signifi-3 and 4). Abdominal ultrasonography revealed fatty liver cant complications among BMT recipients; however, because changes for one patient only (case 5). All five patients received of the small number of infected patients, an extensive analysis praziquantel (25 mg/kg po t.i.d. for 1 day) before undergoing of risk factors or outcomes is not possible. Rates of complicabone marrow transplantation. None of the patients developed tions such as VOD and mortality for infected patients do not bacteremia. Only two patients who underwent allogeneic transdiffer significantly from those for noninfected patients. This is plantation had mild VOD of the liver (cases 1 and 2), with in contrast to a series of 89 allogeneic BMT recipients in Egypt, hyperbilirubinemia and mildly elevated liver enzyme levels.
among whom five with schistosomal hepatic periportal fibrosis After praziquantel treatment, each of the three consecutive subdetected by pretransplantation ultrasonography died of severe sequent stool examinations for all five patients were negative VOD despite initial normal liver function and absence of portal for C. sinensis ova; in addition, Salmonella species were not hypertension [9] . Because there was no evidence of periportal detected after ciprofloxacin prophylaxis. All five patients surfibrosis in our patients, it is not surprising that the incidence of VOD was comparable to that for uninfected BMT recipients. vived for ú300 days. / 9c52$$au20 07-14-98 16:40:15 cida UC: CID
The association of clonorchiasis with cholangiocarcinoma among immunocompromised patients. Because all BMT recipients had severe underlying disease, and C. sinensis adult worms and recurrent pyogenic cholangitis in areas of endemicity was not evident among our BMT recipients, and throughout the can act as nidi for Salmonella species, it is not surprising that BMT recipients with clonorchiasis had a higher rate of course of transplantation none of them had bacteremia. C. sinensis initiates inflammatory and proliferative reactions in the Salmonella carriage. Although the host defense against C. sinensis is not combiliary epithelium with which the parasite makes contact, leading to encapsulating fibrosis of the ducts. Repeated exposure pletely understood, in the absence of solid evidence concerning the adverse effects of immunosuppression on the clinical course to C. sinensis in distal bile passages provokes considerable local tissue reaction as a result of mechanical irritation and of clonorchiasis, low worm burdens in the general population, and with the availability of effective antihelminthic agents, toxic products, formation of new bile capillaries, mucinous glands and periportal connective tissue hyperplasia, and perieclonorchiasis is not a contraindication to bone marrow transplantation, and no excessive complications are expected. pithelial fibrosis. In addition, there is colonization of bile by bacteria predisposing to cholangitis and bacteremia. These complications are progressive, and their ultimate effect on liver
